Shernan Holtan, MD

Videos

Frontline Treatment Options for Acute Graft-Versus-Host Disease

11/13/2023

Shernan Holtan, MD, explores advances and unmet needs in the frontline treatment of patients with acute graft-versus-host-disease.

Shernan Holtan, MD, explores...

11/13/2023

Oncology

Shernan G Holtan, MD, University of Minnesota

Conference Coverage

Selective Oral AURKA Inhibitor for Graft-Versus-Host Disease and Relapse Prophylaxis Following Allogeneic HCT

12/21/2023

Shernan Holtan , MD;

At the 2023 ASH Annual Meeting, Shernan G Holtan, MD, shares data from a trial of post-transplant cyclophosphamide plus sirolimus combined with VIC-1911, a selective oral AURKA inhibitor, for patients with GVHD and relapse prophylaxis after...

At the 2023 ASH Annual Meeting,...

12/21/2023

Oncology

Videos

Latest Updates in Graft-Versus-Host Disease Prophylaxis

11/13/2023

Shernan Holtan , MD;

Shernan Holtan, MD, explores the most recent data in terms of graft-versus-host-disease prophylaxis.

Shernan Holtan, MD, explores the...

11/13/2023

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Shernan Holtan, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products